MacroLensNP नेपालीने Sign in Create accountSign up
Free · Hotel & Tourism

SHL Soaltee Hotel Limited

Rs 545.00 -1.90 (-0.35%) as of 2026-11-06 15:00:00
Open
540.00
High
560.00
Low
540.00
Prev. close
546.90
Volume
49,526
Turnover
2.70 crore
Avg volume (30 d)
70,883
52-week low Rs 464.00
high Rs 560.00 -2.7% from the 52-week high

Soaltee Hotel Limited (SHL) is listed on the Nepal Stock Exchange in the Hotel & Tourism sector. Its share price is Rs 545.00 as of 6 November 2026, 2.7% below its 52-week high of Rs 560.00 and 17.5% above its 52-week low of Rs 464.00. It trades at a P/E of 84.1 on earnings per share of Rs 6.48, close to the Hotel & Tourism sector's median P/E of 84.1.

SHL paid a dividend in 6 of the last 8 fiscal years we track; the latest was 16.58% cash and 15.00% bonus for FY 2081/2082. Promoters hold 69% of the shares and the public 31%.

Key figures latest report 2082/2083 Q4

Market value
640.46 crore · 6.40 arba
Shares listed
11,751,525
Paid-up capital
11.75 lakh
EPS (annualised)
Rs 6.48
P/E
84.1
Book value / share
Rs 28.52
P/B
19.11
ROE
22.7%
ROA
19.07%
Dividend yield
3.04%
Net profit (annualised)
7.61 lakh
Reserves
21.77 lakh
Total assets
39.92 lakh
Debt to equity
–

Quarter by quarter trailing 12 months at each quarter

QuarterEPSEPS growth (y/y)Net profitRevenueROE
2082/2083 Q4 6.48 +13.5% 76.11 crore 314.81 crore · 3.15 arba 25.2%
2082/2083 Q3 6.42 +14.9% 75.40 crore 312.91 crore · 3.13 arba 26.3%
2082/2083 Q2 6.10 +12.0% 71.65 crore 301.02 crore · 3.01 arba 26.4%
2082/2083 Q1 5.73 +8.6% 67.32 crore 288.36 crore · 2.88 arba 25.6%
2081/2082 Q4 5.71 +11.6% 67.07 crore 277.01 crore · 2.77 arba 26.6%
2081/2082 Q3 5.58 +11.9% 65.61 crore 270.73 crore · 2.71 arba 27.1%
2081/2082 Q2 5.44 +14.9% 63.97 crore 266.63 crore · 2.67 arba 26.8%
2081/2082 Q1 5.27 +15.8% 61.98 crore 261.22 crore · 2.61 arba 26.5%

Dividends

Fiscal yearBonusCashBook close
2081/208215.00% 16.58% 21 Nov 2025
2080/208110.00% 26.84% 28 Nov 2024
2079/20805.00% 26.58% 21 Dec 2023
2078/20795.00% 21.32% 22 Dec 2022
2077/2078– – –
2076/2077– – –
2075/207615.00% 11.31% 11 Dec 2019
2074/207510.00% 16.31% 12 Dec 2018

Bonus / right shares: Nov 2025 Bonus share 15% · Nov 2024 Bonus share 10% · Dec 2023 Bonus share 5% · Dec 2022 Bonus share 5%

Who owns it

Promoters 69% Public 31%
Public float
36,428,413 shares
Mutual funds hold
3.9% of the float
Promoter lock-in
–

MacroLens analysis of SHL

More on SHL on the full desk The rating and verdict, fair value, dump risk and warning signs, the 12-month target, the buy / sell meter with every past signal, cornering and broker activity - the analysis behind every number above. Create an account - 7-day trial

Other Hotel & Tourism companies

CompanyPriceTodayP/EP/BMarket value
TRH Taragaon Regency Hotel Limited 835.00 +1.58% –7.03 1,638 crore · 16.38 arba
BANDIPUR Bandipur Cablecar and Tourism... 553.00 -0.02% –6.05 1,565 crore · 15.65 arba
CGH Chandragiri Hills Limited 728.00 +0.64% 142.26.87 1,173 crore · 11.73 arba
HFIN Hotel Forest Inn Limited 514.90 +0.18% –4.80 1,030 crore · 10.30 arba
CITY City Hotel Limited 321.90 -0.03% –3.35 969.95 crore · 9.70 arba
OHL Oriental Hotels Limited 643.90 +0.45% –1.97 762.70 crore · 7.63 arba
KDL Kalinchowk Darshan Limited 498.20 -2.70% 54.44.56 340.54 crore · 3.41 arba

Every Hotel & Tourism company 8

Browse all NEPSE stocks by sector →

SHL: common questions

What is the share price of SHL today?

SHL (Soaltee Hotel Limited) closed at Rs 545.00 as of 6 November 2026 on NEPSE.

Does SHL pay dividends?

SHL paid a dividend in 6 of the last 8 fiscal years we track; the latest was 16.58% cash and 15.00% bonus for FY 2081/2082.

What is the P/E ratio of SHL?

It trades at a P/E of 84.1 on earnings per share of Rs 6.48, close to the Hotel & Tourism sector's median P/E of 84.1.

Is SHL a good buy?

This page is not buy or sell advice. MacroLens NP rates every NEPSE company on its fundamentals - SHL's rating, fair value, dump risk and broker activity are on the desk, free for 7 days.

Prices from NEPSE; figures from the company's quarterly reports; dividends, ownership and news from public filings. Research, not a recommendation to buy or sell - see the risk disclosure.